Effect of the Silica–Magnetite Nanocomposite Coating Functionalization on the Doxorubicin Sorption/Desorption
Электронный научный архив УРФУ
Информация об архиве | Просмотр оригинала| Поле | Значение | |
| Заглавие |
Effect of the Silica–Magnetite Nanocomposite Coating Functionalization on the Doxorubicin Sorption/Desorption
|
|
| Автор |
Demin, A. M.
Vakhrushev, A. V. Valova, M. S. Korolyova, M. A. Uimin, M. A. Minin, A. S. Pozdina, V. A. Byzov, I. V. Tumashov, A. A. Chistyakov, K. A. Levit, G. L. Krasnov, V. P. Charushin, V. N. |
|
| Тематика |
DFT CALCULATIONS
DOXORUBICIN FE3O4 NANOPARTICLES NANOCOMPOSITES PMIDA SIO2 SORPTION/DESORPTION ACETIC ACID DERIVATIVE DOXORUBICIN MAGNETITE N (PHOSPHONOMETHYL)IMINODIACETIC ACID NANOCOMPOSITE SILICON DIOXIDE UNCLASSIFIED DRUG ARTICLE CANCER CHEMOTHERAPY DENSITY FUNCTIONAL THEORY DESORPTION DRUG COATING DRUG RELEASE IC50 IN VITRO STUDY MOLECULARLY TARGETED THERAPY PH PHYSICAL PHENOMENA SORPTION |
|
| Описание |
A series of new composite materials based on Fe3O4 magnetic nanoparticles coated with SiO2 (or aminated SiO2) were synthesized. It has been shown that the use of N-(phosphonomethyl)iminodiacetic acid (PMIDA) to stabilize nanoparticles before silanization ensures the increased content of a SiO2 phase in the Fe3O4@SiO2 nanocomposites (NCs) in comparison with materials obtained under similar conditions, but without PMIDA. It has been demonstrated for the first time that the presence of PMIDA on the surface of NCs increases the level of Dox loading due to specific binding, while surface modification with 3-aminopropylsilane, on the contrary, significantly reduces the sorption capacity of materials. These regularities were in accordance with the results of quantum chemical calculations. It has been shown that the energies of Dox binding to the functional groups of NCs are in good agreement with the experimental data on the Dox sorption on these NCs. The mechanisms of Dox binding to the surface of NCs were proposed: simultaneous coordination of Dox on the PMIDA molecule and silanol groups at the NC surface leads to a synergistic effect in Dox binding. The synthesized NCs exhibited pH-dependent Dox release, as well as dose-dependent cytotoxicity in in vitro experiments. The cytotoxic effects of the studied materials correspond to their calculated IC50 values. NCs with a SiO2 shell obtained using PMIDA exhibited the highest effect. At the same time, the presence of PMIDA in NCs makes it possible to increase the Dox loading, as well as to reduce its desorption rate, which may be useful in the design of drug delivery vehicles with a prolonged action. We believe that the data obtained can be further used to develop stimuli-responsive materials for targeted cancer chemotherapy. © 2022 by the authors.
Ministry of Education and Science of the Russian Federation, Minobrnauka, (075-15-2020-777) This research was funded by the Ministry of Science and Higher Education of the Russian Federation, grant number 075-15-2020-777. |
|
| Дата |
2024-04-08T11:06:59Z
2024-04-08T11:06:59Z 2022 |
|
| Тип |
Article
Journal article (info:eu-repo/semantics/article) Published version (info:eu-repo/semantics/publishedVersion) |
|
| Идентификатор |
Demin, AM, Vakhrushev, AV, Valova, MS, Korolyova, MA, Uimin, MA, Minin, AS, Pozdina, VA, Byzov, IV, Tumashov, AA, Chistyakov, KA, Levit, GL, Krasnov, VP & Charushin, VN 2022, 'Effect of the Silica–Magnetite Nanocomposite Coating Functionalization on the Doxorubicin Sorption/Desorption', Pharmaceutics, Том. 14, № 11, 2271. https://doi.org/10.3390/pharmaceutics14112271
Demin, A. M., Vakhrushev, A. V., Valova, M. S., Korolyova, M. A., Uimin, M. A., Minin, A. S., Pozdina, V. A., Byzov, I. V., Tumashov, A. A., Chistyakov, K. A., Levit, G. L., Krasnov, V. P., & Charushin, V. N. (2022). Effect of the Silica–Magnetite Nanocomposite Coating Functionalization on the Doxorubicin Sorption/Desorption. Pharmaceutics, 14(11), [2271]. https://doi.org/10.3390/pharmaceutics14112271 1999-4923 Final All Open Access; Gold Open Access; Green Open Access https://www.mdpi.com/1999-4923/14/11/2271/pdf?version=1667286838 https://www.mdpi.com/1999-4923/14/11/2271/pdf?version=1667286838 http://elar.urfu.ru/handle/10995/131381 10.3390/pharmaceutics14112271 85141751876 000882167700001 |
|
| Язык |
en
|
|
| Права |
Open access (info:eu-repo/semantics/openAccess)
cc-by https://creativecommons.org/licenses/by/4.0/ |
|
| Формат |
application/pdf
|
|
| Издатель |
MDPI
|
|
| Источник |
Pharmaceutics
Pharmaceutics |
|